HERA W10 Diagnostic Ultrasound System; HERA W9 Diagnostic Ultrasound System

Samsung Medison CO., LTD. · K230084 · 2023-04-21

HERA W10 Diagnostic Ultrasound System; HERA W9 Diagnostic Ultrasound System is an AI-enabled medical device from Samsung Medison CO., LTD., listed by FDA (510(k), K230084) with a decision date of 2023-04-21. Review panel: Radiology.

FDA submission numberK230084
Pathway510(k)
CompanySamsung Medison CO., LTD.
Review panel (specialty)Radiology
FDA decision date2023-04-21
DecisionSubstantially Equivalent
Product codeIYN
ClassificationSystem, Imaging, Pulsed Doppler, Ultrasonic
Device class2
Regulation number892.1550
Review time (calendar days)100
Applicant countryKR

Official FDA database record · FDA AI-enabled device list

More devices from Samsung Medison CO., LTD. · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.